Physician profile
Adam Cohen
NPI 1104036516
$26,598.32
in general payments reported to CMS, 2019-2025
60 companies · $6,363 in 2025
The $6,363 reported for 2025 was more than what 97% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,858 · 2020: $1,250 · 2021: $953 · 2022: $3,680 · 2023: $6,924 · 2024: $3,572 · 2025: $6,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,339 · Consulting Fee: $7,310 · Travel and Lodging: $124 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,338.82 |
| Consulting Fee | $7,310.00 |
| Travel and Lodging | $124.45 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $6,757.51 | 2019-2025 | Eliquis |
| Amgen INC. | $2,943.71 | 2019-2025 | Repatha, Otezla, Repatha |
| F. Hoffmann-La Roche Ag | $2,554.99 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $1,429.11 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $1,339.50 | 2019-2025 | |
| Novo Nordisk INC | $1,242.81 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $1,021.96 | 2019-2025 | Spravato |
| Lilly USA, LLC | $974.62 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $796.12 | 2019-2025 | Vraylar, Ubrelvy |
| Astellas Pharma US INC | $749.60 | 2019-2025 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $626.80 | 2019-2024 | Jardiance, Synjardy, Tradjenta |
| Boston Scientific Corporation | $536.52 | 2019-2024 | Watchman Flx, Watchman Access System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $393.90 | 2022-2025 | Xifaxan, Trulance |
| Gilead Sciences, INC. | $361.12 | 2019-2020 | |
| Eisai INC. | $357.65 | 2019-2025 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $357.30 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Merck Sharp & Dohme LLC | $348.43 | 2019-2020 | |
| Amarin Pharma, INC. | $344.14 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $284.95 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $277.00 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $260.86 | 2024-2025 | Caplyta |
| Glaxosmithkline, LLC. | $210.30 | 2019-2024 | |
| Ardelyx, INC. | $203.90 | 2024-2025 | Ibsrela |
| Teva Pharmaceuticals USA, INC. | $202.59 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $172.61 | 2019 | |
| Sumitomo Pharma America, INC. | $171.35 | 2025 | Gemtesa |
| Tolmar, INC. | $143.89 | 2024-2025 | Jatenzo |
| Corium, LLC | $133.29 | 2022-2023 | Adlarity |
| Intuity Medical INC | $131.85 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Allergan, INC. | $100.51 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $99.52 | 2023-2025 | Nuedexta, Rexulti |
| Halozyme INC | $87.77 | 2023 | |
| Radius Health, INC. | $87.39 | 2023-2025 | Tymlos |
| Mylan Specialty L.P. | $80.93 | 2022-2024 | Yupelri |
| Exact Sciences Corporation | $78.26 | 2023-2024 | Cologuard Collection Kit |
| Abbott Laboratories | $71.18 | 2023-2024 | Freestyle Libre 3 |
| Esperion Therapeutics, INC. | $64.36 | 2024-2025 | Nexletol |
| Renalytix Ai, INC. | $45.71 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Kowa Pharmaceuticals America, INC. | $43.85 | 2022 | |
| Genentech USA, INC. | $41.34 | 2019-2022 | |
| Biogen, INC. | $39.69 | 2021 | |
| Ibsa Pharma INC. | $38.55 | 2019 | |
| Celgene Corporation | $38.38 | 2019 | |
| Baxter Healthcare | $34.35 | 2024 | Hillrom - Connex Spot Monitor |
| Corcept Therapeutics | $30.85 | 2025 | Korlym |
| Mimedx Group, INC. | $26.54 | 2024 | |
| Irhythm Technologies, INC. | $26.53 | 2024 | Zio Monitor, Zio Xt Patch |
| Insightec,INC | $24.81 | 2025 | Exablate |
| Inspire Medical Systems, INC. | $24.20 | 2025 | Inspire |
| Ironwood Pharmaceuticals, INC | $22.78 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $19.87 | 2025 | Neffy |
| Valinor Pharma, LLC | $19.75 | 2023 | Movantik |
| Forte Bio-Pharma LLC | $19.51 | 2025 | Prolate, Nalocet, Tanlor |
| Vivus LLC | $19.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.00 | 2022 | |
| Acerus Pharmaceuticals Corporation | $18.05 | 2022 | |
| Clarus Therapeutics INC. | $17.00 | 2021 | |
| Aytu Biopharma, INC. | $16.90 | 2020 | |
| Horizon Therapeutics Plc | $13.36 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.